Newsmaker Breakfast - The CDR and Rare DiseasesHosting Organizations: CORD (Canadian Organization for Rare Disorders) Contact: Steve Lott Website: http://www.raredisorders.ca |
||||||||||||
|
Durhane Wong-Rieger, President of the Canadian Organization for Rare Disorders (CORD), will challenge the Canadian government to respond to charges made by patients and families with rare disorders that they are being unjustly denied potentially life-saving medicines. They feel that our national drug review agency – the Common Drug Review (CDR) – is applying an inappropriate, inadequate and unethical health economic assessment to orphan drugs, resulting in the denial of nearly every orphan drug presented to the CDR. The Standing Committee on Health is evaluating the CDR and will hear testimony on April 25th from the Federal, Provincial and Territorial governments that fund and operate the CDR. “We felt it was essential that Committee members have in mind the concerns of the patients as they listen to the government managers of CDR,” says Wong-Rieger.
For more information, please contact: |
||||||||||||
| Event Home |